None. Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the 
Indonesian healthcare setting. Fakultas Farmasi UGM; 2022. oai:ais:library-item:7763